健康元药业集团股份有限公司申请I类会议

Group 1 - The core point of the news is that Health元药业集团股份有限公司 has applied for an "I class meeting" with the CDE, which is currently in processing status [1] - The I class meeting is typically held within 30 days after the application and addresses significant safety issues in drug clinical trials or major technical issues in the development of breakthrough therapies [1] - Health元药业集团股份有限公司 was established in 1992 and is primarily engaged in the pharmaceutical manufacturing industry, with a registered capital of 1,874.20042 million RMB [1] Group 2 - The company has made investments in 31 enterprises and participated in 174 bidding projects, indicating active engagement in the market [1] - Health元药业集团股份有限公司 holds 893 trademark registrations and 156 patents, showcasing its focus on intellectual property [1] - The company has 106 administrative licenses, reflecting its compliance and operational capabilities [1] Group 3 - Major shareholders of Health元药业集团股份有限公司 include Shenzhen百业源投资有限公司 with a 48.96% stake, Hong Kong Central Clearing Limited with 3.74%, and others [2] - The ownership structure indicates a significant concentration of ownership with the largest shareholder holding nearly half of the company [2]